Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.

Oncology reports - 1 Jan 2000

Salmon R J, Ansquer Y, Asselain B, Languille O, Lesec G, Remvikos Y

Abstract excerpt

The paradox of an excess breast cancer incidence among current users of hormone replacement therapy (HRT) without excess in breast cancer mortality raises the question of possible differences in the clinical and biological characteristics of cancers in current HRT users compared to non-users. A consecutive series of 129 post-menopausal patients under HRT for at least 6 months, in whom an operable breast cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms
Share to Estradiol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hormone Replacement Therapy

Share to Neoplasm Staging

Share to Postmenopause

Share to Progesterone

Share to Receptors, Progesterone

Source

Identifiers

PMID: 10203618
DOI: 10.3892/or.6.3.699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.PMID 10203618Read ↗

The menopause, hormone replacement therapy and breast cancer.Semantic proximity Read ↗

Hormonal contraceptives and breast cancer: Clinical data.Semantic proximity Read ↗

The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis.Semantic proximity Read ↗

Is HRT justified for symptom management in women at higher risk of developing breast cancer?Semantic proximity Read ↗

[Breast cancer in women thirty years old or less].Semantic proximity Read ↗

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort studySemantic proximity Read ↗

The estrogen receptor negative-progesterone receptor positive breast carcinoma is a biological entity and not a technical artifact.Semantic proximity Read ↗

Age‐related phenotypes in breast cancer: A population‐based studySemantic proximity Read ↗

Hormone replacement therapy and elevated breast cancer risk: An artifact of growth acceleration?Semantic proximity Read ↗

Exogenous reproductive hormone use in breast cancer survivors and previvors.Semantic proximity Read ↗

Circulating estradiol defines the tumor phenotype in menopausal breast cancer patients.Semantic proximity Read ↗

Hormone Replacement Therapy Appears to Be Safe After Prophylactic Adnexectomy in Premenopausal BRCA1/BRCA2 Mutation Carriers. Reaction to the 'Letter to readers' in Hereditary Cancer in Clinical Practice, 2005, 3 (2)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.